nodes	percent_of_prediction	percent_of_DWPC	metapath
Clorazepate—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0597	0.281	CcSEcCtD
Clorazepate—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0414	0.0904	CbGeAlD
Clorazepate—TSPO—appendage—amyotrophic lateral sclerosis	0.0355	0.0776	CbGeAlD
Clorazepate—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0235	0.111	CcSEcCtD
Clorazepate—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.0223	0.0487	CbGeAlD
Clorazepate—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.0204	0.0445	CbGeAlD
Clorazepate—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0197	0.043	CbGeAlD
Clorazepate—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0761	CcSEcCtD
Clorazepate—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.0153	0.658	CrCbGaD
Clorazepate—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0715	CcSEcCtD
Clorazepate—GABRB2—brainstem—amyotrophic lateral sclerosis	0.0128	0.0279	CbGeAlD
Clorazepate—TSPO—embryo—amyotrophic lateral sclerosis	0.0118	0.0258	CbGeAlD
Clorazepate—GABRA2—brainstem—amyotrophic lateral sclerosis	0.0117	0.0255	CbGeAlD
Clorazepate—GABRA1—brainstem—amyotrophic lateral sclerosis	0.0113	0.0246	CbGeAlD
Clorazepate—TSPO—brainstem—amyotrophic lateral sclerosis	0.0108	0.0236	CbGeAlD
Clorazepate—Tension—Riluzole—amyotrophic lateral sclerosis	0.00954	0.045	CcSEcCtD
Clorazepate—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00944	0.0445	CcSEcCtD
Clorazepate—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0091	0.0429	CcSEcCtD
Clorazepate—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00891	0.0195	CbGeAlD
Clorazepate—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00891	0.0195	CbGeAlD
Clorazepate—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00882	0.0193	CbGeAlD
Clorazepate—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00849	0.0186	CbGeAlD
Clorazepate—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00821	0.0179	CbGeAlD
Clorazepate—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00809	0.0381	CcSEcCtD
Clorazepate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.008	0.0377	CcSEcCtD
Clorazepate—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00794	0.0174	CbGeAlD
Clorazepate—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00794	0.0174	CbGeAlD
Clorazepate—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00791	0.0173	CbGeAlD
Clorazepate—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00787	0.0172	CbGeAlD
Clorazepate—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.00754	0.0165	CbGeAlD
Clorazepate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00717	0.0338	CcSEcCtD
Clorazepate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00705	0.0332	CcSEcCtD
Clorazepate—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00701	0.0153	CbGeAlD
Clorazepate—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00684	0.0149	CbGeAlD
Clorazepate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00684	0.0322	CcSEcCtD
Clorazepate—GABRA5—brain—amyotrophic lateral sclerosis	0.00674	0.0147	CbGeAlD
Clorazepate—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00672	0.0147	CbGeAlD
Clorazepate—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00669	0.0146	CbGeAlD
Clorazepate—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00669	0.0146	CbGeAlD
Clorazepate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00654	0.0308	CcSEcCtD
Clorazepate—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00644	0.0141	CbGeAlD
Clorazepate—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00644	0.0141	CbGeAlD
Clorazepate—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.0063	0.0138	CbGeAlD
Clorazepate—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.0063	0.0138	CbGeAlD
Clorazepate—GABRA3—brain—amyotrophic lateral sclerosis	0.00628	0.0137	CbGeAlD
Clorazepate—GABRB2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00619	0.0202	CbGpPWpGaD
Clorazepate—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00612	0.0134	CbGeAlD
Clorazepate—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.0061	0.0133	CbGeAlD
Clorazepate—GABRA5—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00601	0.0196	CbGpPWpGaD
Clorazepate—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00591	0.0129	CbGeAlD
Clorazepate—GABRA3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0059	0.0192	CbGpPWpGaD
Clorazepate—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00589	0.0129	CbGeAlD
Clorazepate—GABRA2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0058	0.0189	CbGpPWpGaD
Clorazepate—GABRB3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00576	0.0188	CbGpPWpGaD
Clorazepate—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00576	0.0126	CbGeAlD
Clorazepate—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00569	0.0124	CbGeAlD
Clorazepate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00569	0.0268	CcSEcCtD
Clorazepate—TSPO—nervous system—amyotrophic lateral sclerosis	0.00566	0.0124	CbGeAlD
Clorazepate—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00566	0.0185	CbGpPWpGaD
Clorazepate—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00556	0.0121	CbGeAlD
Clorazepate—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00545	0.0119	CbGeAlD
Clorazepate—TSPO—cerebellum—amyotrophic lateral sclerosis	0.00533	0.0116	CbGeAlD
Clorazepate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00524	0.0247	CcSEcCtD
Clorazepate—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00514	0.0112	CbGeAlD
Clorazepate—GABRB2—brain—amyotrophic lateral sclerosis	0.00512	0.0112	CbGeAlD
Clorazepate—GABRG2—brain—amyotrophic lateral sclerosis	0.00512	0.0112	CbGeAlD
Clorazepate—Rash—Riluzole—amyotrophic lateral sclerosis	0.005	0.0236	CcSEcCtD
Clorazepate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.005	0.0235	CcSEcCtD
Clorazepate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00497	0.0234	CcSEcCtD
Clorazepate—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00495	0.0108	CbGeAlD
Clorazepate—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00495	0.0161	CbGpPWpGaD
Clorazepate—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00484	0.0106	CbGeAlD
Clorazepate—GABRA2—brain—amyotrophic lateral sclerosis	0.00467	0.0102	CbGeAlD
Clorazepate—GABRA1—brain—amyotrophic lateral sclerosis	0.00452	0.00987	CbGeAlD
Clorazepate—TSPO—brain—amyotrophic lateral sclerosis	0.00433	0.00945	CbGeAlD
Clorazepate—GABRB3—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.00402	0.0131	CbGpPWpGaD
Clorazepate—GABRB3—brain—amyotrophic lateral sclerosis	0.00393	0.00858	CbGeAlD
Clorazepate—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0035	0.0114	CbGpPWpGaD
Clorazepate—GABRA5—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0034	0.0111	CbGpPWpGaD
Clorazepate—Fenbufen—PTGS2—amyotrophic lateral sclerosis	0.0034	0.146	CrCbGaD
Clorazepate—GABRA3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00334	0.0109	CbGpPWpGaD
Clorazepate—GABRA2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00328	0.0107	CbGpPWpGaD
Clorazepate—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00326	0.0106	CbGpPWpGaD
Clorazepate—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0032	0.0104	CbGpPWpGaD
Clorazepate—Oxaprozin—PTGS2—amyotrophic lateral sclerosis	0.00295	0.127	CrCbGaD
Clorazepate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00285	0.00927	CbGpPWpGaD
Clorazepate—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0028	0.00913	CbGpPWpGaD
Clorazepate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00276	0.00901	CbGpPWpGaD
Clorazepate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00271	0.00885	CbGpPWpGaD
Clorazepate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00267	0.0087	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00265	0.00864	CbGpPWpGaD
Clorazepate—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00263	0.00575	CbGeAlD
Clorazepate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00263	0.00856	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0026	0.00848	CbGpPWpGaD
Clorazepate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00255	0.00832	CbGpPWpGaD
Clorazepate—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00253	0.00553	CbGeAlD
Clorazepate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00251	0.00817	CbGpPWpGaD
Clorazepate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00246	0.00802	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00245	0.008	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00245	0.00797	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0024	0.00783	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00239	0.00779	CbGpPWpGaD
Clorazepate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00232	0.00756	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00227	0.00741	CbGpPWpGaD
Clorazepate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00225	0.00735	CbGpPWpGaD
Clorazepate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00221	0.00721	CbGpPWpGaD
Clorazepate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00217	0.00709	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00216	0.00704	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00214	0.00697	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00212	0.00692	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0021	0.00684	CbGpPWpGaD
Clorazepate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00209	0.00682	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00208	0.00677	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00204	0.00665	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00201	0.00654	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00199	0.00649	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00197	0.00643	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00196	0.00638	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00192	0.00625	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00191	0.00621	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00188	0.00614	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00185	0.00604	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00185	0.00604	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00185	0.00603	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00184	0.00599	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00182	0.00593	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00181	0.00589	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00179	0.00583	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00178	0.00579	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00174	0.00568	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00174	0.00568	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00171	0.00557	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00171	0.00557	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00169	0.00552	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00166	0.00542	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00164	0.00534	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00163	0.00533	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00162	0.00529	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00162	0.00528	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00162	0.00528	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00159	0.0052	CbGpPWpGaD
Clorazepate—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.00159	0.0685	CrCbGaD
Clorazepate—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00159	0.00519	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00158	0.00515	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00158	0.00515	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00158	0.00515	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00158	0.00514	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00157	0.00513	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00157	0.00513	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00156	0.0051	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00155	0.00504	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00155	0.00504	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00154	0.00501	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00153	0.00498	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00152	0.00497	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00152	0.00495	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00152	0.00495	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00151	0.00493	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00151	0.00492	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00151	0.00492	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0015	0.00489	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00148	0.00483	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00148	0.00483	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00147	0.00479	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00146	0.00476	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00144	0.00471	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00144	0.0047	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00142	0.00463	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00142	0.00462	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00141	0.00459	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0014	0.00458	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00139	0.00454	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00139	0.00454	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00138	0.00451	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00138	0.00449	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00137	0.00446	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00136	0.00443	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00135	0.00442	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00135	0.0044	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00135	0.00439	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00134	0.00436	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00134	0.00436	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00132	0.00431	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00131	0.00427	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0013	0.00423	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0013	0.00422	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0013	0.00422	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00127	0.00415	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00125	0.00408	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00124	0.00406	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00124	0.00405	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00124	0.00405	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00122	0.00398	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00122	0.00397	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00121	0.00394	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00121	0.00393	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00121	0.00393	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00118	0.00386	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00118	0.00386	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00118	0.00386	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.00381	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00116	0.0038	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.0038	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00116	0.00379	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00116	0.00377	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00377	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00116	0.00377	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00114	0.00372	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00114	0.0037	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00114	0.0037	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00114	0.0037	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00111	0.00363	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00111	0.00361	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00351	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00107	0.00348	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00106	0.00344	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00104	0.00338	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00336	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00102	0.00331	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00101	0.0033	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000993	0.00324	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000993	0.00324	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000974	0.00318	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000885	0.00288	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000818	0.00267	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000785	0.00256	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000763	0.00249	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000749	0.00244	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000736	0.0024	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000732	0.00238	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000718	0.00234	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000668	0.00218	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000668	0.00218	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000649	0.00211	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000649	0.00211	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000637	0.00208	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000637	0.00208	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000628	0.00205	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000626	0.00204	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000626	0.00204	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000622	0.00203	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000622	0.00203	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000611	0.00199	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000611	0.00199	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000595	0.00194	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000578	0.00188	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000568	0.00185	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000558	0.00182	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000554	0.00181	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000544	0.00177	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000543	0.00177	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000534	0.00174	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000534	0.00174	CbGpPWpGaD
Clorazepate—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000508	0.00165	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000476	0.00155	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000409	0.00133	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000347	0.00113	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000243	0.000792	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00024	0.000781	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000186	0.000607	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000186	0.000607	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00017	0.000555	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000158	0.000516	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000149	0.000485	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000135	0.000439	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000102	0.000332	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.41e-05	0.000307	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.73e-05	0.000252	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.15e-05	0.000135	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.82e-05	0.000124	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.14e-05	0.000102	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.15e-05	7.01e-05	CbGpPWpGaD
